1380P PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 35; pp. S866 - S867
Main Authors Ciccolini, J., Hamimed, M., Marolleau, S., Perez, C., Benzekry, S., Le Ray, M., Boyer, A., Audigier-Valette, C., Martinez, S., Pegliasco, H., Ray, P., Falchero, L., Serre, A., Cloarec, N., Lebas, L., Hominal, S., Mazieres, J., Pérol, M., Greillier, L., Barlesi, F.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2024
Online AccessGet full text

Cover

Author Pérol, M.
Benzekry, S.
Martinez, S.
Hominal, S.
Lebas, L.
Le Ray, M.
Serre, A.
Barlesi, F.
Ciccolini, J.
Marolleau, S.
Mazieres, J.
Greillier, L.
Falchero, L.
Perez, C.
Cloarec, N.
Hamimed, M.
Boyer, A.
Audigier-Valette, C.
Ray, P.
Pegliasco, H.
Author_xml – sequence: 1
  givenname: J.
  surname: Ciccolini
  fullname: Ciccolini, J.
  organization: Biogenopôle, Assistance Publique Hopitaux de Marseille, Marseille, France
– sequence: 2
  givenname: M.
  surname: Hamimed
  fullname: Hamimed, M.
  organization: SMARTc CRCM, Aix-Marseille University - Faculté de Médecine - Timone, Marseille, France
– sequence: 3
  givenname: S.
  surname: Marolleau
  fullname: Marolleau, S.
  organization: SMARTc CRCM, Aix Marseille University, Marseille, France
– sequence: 4
  givenname: C.
  surname: Perez
  fullname: Perez, C.
  organization: SMARTc CRCM, Aix Marseille University, Marseille, France
– sequence: 5
  givenname: S.
  surname: Benzekry
  fullname: Benzekry, S.
  organization: COMPO, INRIA Head Office, Marseille, France
– sequence: 6
  givenname: M.
  surname: Le Ray
  fullname: Le Ray, M.
  organization: Aix Marseille University, Marseille, France
– sequence: 7
  givenname: A.
  surname: Boyer
  fullname: Boyer, A.
  organization: Thoracic Oncology, Fondation Hopital Saint Joseph, Marseille, France
– sequence: 8
  givenname: C.
  surname: Audigier-Valette
  fullname: Audigier-Valette, C.
  organization: Pneumology, Hospital Sainte Musse, Toulon, France
– sequence: 9
  givenname: S.
  surname: Martinez
  fullname: Martinez, S.
  organization: Pneumology, CH du Pays d'Aix, Aix-en-Provence, France
– sequence: 10
  givenname: H.
  surname: Pegliasco
  fullname: Pegliasco, H.
  organization: Pneumology, Hopital Européen Marseille, Marseille, France
– sequence: 11
  givenname: P.
  surname: Ray
  fullname: Ray, P.
  organization: Pneumology, CHU Nimes - Hopital Universitaire Carémeau, Nimes, France
– sequence: 12
  givenname: L.
  surname: Falchero
  fullname: Falchero, L.
  organization: Service de Pneumologie et Cancérologie Thoracique, L'Hopital Nord Ouest-Villefranche-Sur-Saone, Villefranche-Sur-Saone, France
– sequence: 13
  givenname: A.
  surname: Serre
  fullname: Serre, A.
  organization: Pneumology, Polycliniques Kenval - Site Valdegour, Nimes, France
– sequence: 14
  givenname: N.
  surname: Cloarec
  fullname: Cloarec, N.
  organization: Service d'Oncologie Médicale et Hématologie Clinique, Centre Hospitalier Henri Duffaut (Avignon), Avignon, France
– sequence: 15
  givenname: L.
  surname: Lebas
  fullname: Lebas, L.
  organization: Pneumology, Centre Hospitalier Universitaire de Toulouse - Hopital Larrey, Toulouse, France
– sequence: 16
  givenname: S.
  surname: Hominal
  fullname: Hominal, S.
  organization: Pneumology, Ch Annecy Genevois Site Annecy, Epagny Metz Tessy, France
– sequence: 17
  givenname: J.
  surname: Mazieres
  fullname: Mazieres, J.
  organization: Thoracic Oncology Department, Centre Hospitalier Universitaire de Toulouse - Hopital Larrey, Toulouse, France
– sequence: 18
  givenname: M.
  surname: Pérol
  fullname: Pérol, M.
  organization: Medical Oncology Department, Centre Léon Bérard, Lyon, France
– sequence: 19
  givenname: L.
  surname: Greillier
  fullname: Greillier, L.
  organization: Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique Hopitaux de Marseille, Marseille, France
– sequence: 20
  givenname: F.
  surname: Barlesi
  fullname: Barlesi, F.
  organization: Thoracic Oncology, Gustave Roussy - Cancer Campus, Villejuif, France
BookMark eNqFkMtOwzAQRb0oEm3hE5D8ASS1EzsPNgiFV0XURlDWlh8T4SpNKjtUar-eRIU1qxnN3Du6c2Zo0nYtIHRDSUgJTRbbULbDSIcRiVhIspCymE_QlORRHKQ8Zpdo5v2WEJLkUT5FNY0zUuHqbVE9YtnK5uitx12N97BTrmvs6Xsn1S1u7aFrxnYQGSx7OP3tsG3x6qMoC7yXvYW293d48wW4Wq5XAO-4d1Y2V-iilo2H6986R5_PT5viNSjXL8vioQw0JREPKKSKGs4VZzWVkUpjlsSpUXIICbXSWZRybZKEJbmEQZETDSyDPEuZlIbTeI74-a52nfcOarF3difdUVAiRkBiK86AxAhIkEyMgAbf_dkHQ7iDBSe8Hn7RYKwD3QvT2X8u_ACOU3RM
ContentType Journal Article
Copyright 2024
Copyright_xml – notice: 2024
DBID AAYXX
CITATION
DOI 10.1016/j.annonc.2024.08.1435
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage S867
ExternalDocumentID 10_1016_j_annonc_2024_08_1435
S0923753424029545
GroupedDBID ---
-E4
.2P
.86
.I3
.XZ
.ZR
08P
0R~
0U7
1TH
23M
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
6J9
70D
AAEDW
AAJKP
AAJQQ
AAKAS
AAKUH
AALRI
AAMVS
AAOGV
AAPNW
AAUQX
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVKL
ABZBJ
ACGFO
ACGFS
ACMRT
ACPQN
ACPRK
ACUFI
ACUTO
ADBBV
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADRIX
ADRTK
ADVLN
ADYVW
ADZCM
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFETI
AFIYH
AFJKZ
AFOFC
AFSHK
AFXEN
AGINJ
AGKEF
AGKRT
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
AQKUS
ASPBG
ATTQO
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BGNMA
BHONS
BTRTY
BVRKM
BZKNY
C1A
CAG
CDBKE
CKLRP
COF
CS3
CZ4
DAKXR
DIK
DILTD
DL5
D~K
E3Z
EBS
EE~
EJD
EX3
F9B
FDB
FEDTE
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
I09
IH2
IHE
IOX
J21
KAQDR
KDC
KOM
KOP
KQ8
KSI
KSN
LAK
M-Z
M41
M49
M4Y
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOYVH
NTWIH
NU-
NU0
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OVD
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RPX
RW1
RXO
RZC
RZE
RZF
RZO
SDH
TCURE
TEORI
TJX
TMA
TR2
U2A
W8F
WOQ
WOW
X7H
YAYTL
YFH
YKOAZ
ZKX
ZXP
~91
0SF
AAYXX
CITATION
ID FETCH-LOGICAL-c1025-1e7b1d55b54f1a2b734637dba380efbc8275cd66469aef1a90ce48e9874aad513
ISSN 0923-7534
IngestDate Wed Oct 09 16:47:04 EDT 2024
Sat Nov 02 16:00:47 EDT 2024
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1025-1e7b1d55b54f1a2b734637dba380efbc8275cd66469aef1a90ce48e9874aad513
ParticipantIDs crossref_primary_10_1016_j_annonc_2024_08_1435
elsevier_sciencedirect_doi_10_1016_j_annonc_2024_08_1435
PublicationCentury 2000
PublicationDate September 2024
2024-09-00
PublicationDateYYYYMMDD 2024-09-01
PublicationDate_xml – month: 09
  year: 2024
  text: September 2024
PublicationDecade 2020
PublicationTitle Annals of oncology
PublicationYear 2024
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
SSID ssj0006929
Score 2.495046
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S866
Title 1380P PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial
URI https://dx.doi.org/10.1016/j.annonc.2024.08.1435
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5wwELa2G6nqpepTTdNWPvS2hYAxxttbRFpF2W6E8lBzQ7Yx0kZdEqW7h-yv79jm4VSrqOkFgYEBPJ9mxh_jMUKfdcQInJFBBWAIwEPrgFdEBeAtdBTJWtWWcJufsKMLenyZXo5Gd17W0nolQ7XZOq_kf7QKbaBXM0v2EZrthUID7IN-YQsahu0_6ThOeFRMihlIKA4nwqsvcqOX0qzHs1kvhf3j0iysHRLSVWdd6U131jAeJ2f5j7yrsfq7y8QowM5qfTqxK3v4UexQdfm6Ufd4-XyhlFkGyOYIHIceP75YOlp13jfOTa7JLy3WloENByN961jtPPQpCUL7nKueWyRJAOMg6pvZJPXs5BlnzPO5cJhtteeOWrgKRdPAB4XmYabiqgnyBgfW_bT_y6_12YZdIttV6cSURkwZ8dKIeYJ2CNgoPkY7B7PTn7PejbMpcYUa228Zpn_tb32f7YGNF6ycv0DP21EGPnCQeYlGunmFns7bPIrXqLbIwcVsvzjEHW7wdY3v4eYL7lEDF1XYRw1eNNiiBneo-YoBM7jFDLaYeYMuvn87z4-CdsWNQMVmXeNYZzKu0lSmtI4FkVlCWZJVUsBL6VoqTrJUVYxRNhUarphGSlOupzyjQlRpnLxFY-gY_Q5hVcnMzGJOVQZRIEmkkFqCM6UgH8YIfBeFXXeVN66wSvmgonYR7zq1bKNDF_WVAJaHb33_2GftoWcDrj-g8ep2rT9C8LmSn1qY_AGHE4E4
link.rule.ids 315,783,787,27938,27939
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1380P+PK%2FPD+analysis+of+pembrolizumab%2C+nivolumab+and+atezolizumab+in+NSCLC+patients%3A+The+PIONeeR+trial&rft.jtitle=Annals+of+oncology&rft.au=Ciccolini%2C+J.&rft.au=Hamimed%2C+M.&rft.au=Marolleau%2C+S.&rft.au=Perez%2C+C.&rft.date=2024-09-01&rft.issn=0923-7534&rft.volume=35&rft.spage=S866&rft.epage=S867&rft_id=info:doi/10.1016%2Fj.annonc.2024.08.1435&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_annonc_2024_08_1435
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon